{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:58:27Z","timestamp":1783101507044,"version":"3.54.6"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Although betamethasone reduces complications of prematurity, it can cause maternal hyperglycemia and neonatal hypoglycemia. Metformin effectively treats maternal hyperglycemia and has been shown to decrease neonatal hypoglycemia in women with gestational diabetes.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To evaluate the impact of metformin treatment after betamethasone administration on maternal glycemic control and the incidence of neonatal hypoglycemia in preterm infants.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This multicenter, open-label randomized clinical trial was conducted from July 1, 2020, to June 30, 2024, at 3 medical centers in Israel. Pregnant women receiving betamethasone from 24.0\u2009to 36.5\u2009gestational weeks due to increased preterm delivery risk were studied. Women with diabetes were excluded.<\/jats:p>\n <\/jats:sec>\n \n Interventions<\/jats:title>\n \n Participants were randomized to metformin (425 mg 3 times daily before meals and 850-1700 mg at 10\n pm<\/jats:sc>\n ) or no treatment. The treatment lasted up to 48 hours after the first betamethasone dose. Capillary glucose was measured before meals (preprandial), 90 minutes after starting meals (postprandial), and at 10\n pm<\/jats:sc>\n .\n <\/jats:p>\n <\/jats:sec>\n \n Main Outcome and Measure<\/jats:title>\n The primary end points were the mean maternal glucose values up to 48 hours from first betamethasone injection and the rate of neonatal hypoglycemia in preterm deliveries (&amp;lt;37 gestational weeks).<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n A total of 169 women (mean [SD] age, 29.7 [5.4] years), including 84 with 48 preterm infants in the metformin group and 85 with 58 preterm neonates in the control group, were included in the study. Mean (SD) maternal total and postprandial glucose values were significantly lower in the metformin group (121\u2009[15] vs 127\u2009[17] mg\/dL;\n P<\/jats:italic>\n \u2009=\u2009.01; and 129\u2009[22] vs 138\u2009[26] mg\/dL;\n P<\/jats:italic>\n \u2009=\u2009.009, respectively). Neonatal hypoglycemia rate was lower in the metformin group (10 [21%] vs 23 [40%];\n P<\/jats:italic>\n \u2009=\u2009.04; relative risk, 0.53; 95% CI, 0.28-0.99). Mild adverse effects, mostly gastrointestinal, were reported by 12 women (14%).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this randomized clinical trial, metformin was safe and effective in preventing betamethasone-induced maternal hyperglycemia and neonatal hypoglycemia. Metformin should be considered as a treatment option for women who receive antenatal corticosteroids to prevent their related adverse effects.<\/jats:p>\n <\/jats:sec>\n \n Trial Registration<\/jats:title>\n \n ClinicalTrials.gov Identifier:\n NCT04332393<\/jats:ext-link>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.52807","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T16:30:36Z","timestamp":1767976236000},"page":"e2552807","source":"Crossref","is-referenced-by-count":1,"title":["Metformin, Maternal Glycemic Control, and Neonatal Hypoglycemia After Antenatal Steroids"],"prefix":"10.1001","volume":"9","author":[{"given":"Enav","family":"Yefet","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Tzafon Medical Center, Poriya, Israel"},{"name":"Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal","family":"Massalha","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Emek Medical Center, Afula, Israel"},{"name":"The Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil","family":"Talmon","sequence":"additional","affiliation":[{"name":"Neonatology Department, Emek Medical Center, Afula, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aminet","family":"Labay","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Tzafon Medical Center, Poriya, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Matanis","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Tzafon Medical Center, Poriya, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erez","family":"Sleman","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Tzafon Medical Center, Poriya, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rima","family":"Nassra","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Tzafon Medical Center, Poriya, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Frank Wolf","sequence":"additional","affiliation":[{"name":"Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel"},{"name":"Raya Strauss Wing of Obstetrics and Gynecology, Galilee Medical Center, Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inshirah","family":"Sgayer","sequence":"additional","affiliation":[{"name":"Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel"},{"name":"Raya Strauss Wing of Obstetrics and Gynecology, Galilee Medical Center, Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lior","family":"Lowenstein","sequence":"additional","affiliation":[{"name":"Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel"},{"name":"Raya Strauss Wing of Obstetrics and Gynecology, Galilee Medical Center, Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohar","family":"Nachum","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Emek Medical Center, Afula, Israel"},{"name":"The Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"issue":"2","key":"zoi251405r1","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1097\/AOG.0000000000002237","article-title":"Committee Opinion No. 713: antenatal corticosteroid therapy for fetal maturation.","volume":"130","author":"Committee on Obstetric Practice","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"4","key":"zoi251405r2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003935.pub5","article-title":"Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes.","volume":"4","author":"Walters","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"zoi251405r3","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004454.pub3","article-title":"Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.","volume":"3","author":"Roberts","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"14","key":"zoi251405r4","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1056\/NEJMoa1516783","article-title":"Antenatal betamethasone for women at risk for late preterm delivery.","volume":"374","author":"Gyamfi-Bannerman","year":"2016","journal-title":"N Engl J Med"},{"key":"zoi251405r5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.diabres.2016.06.005","article-title":"Effect of antenatal betamethasone on blood glucose levels in women with and without diabetes.","volume":"118","author":"Jolley","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"zoi251405r6","first-page":"273","article-title":"Glucocorticoid-associated maternal hyperglycemia: a randomized trial of insulin prophylaxis.","volume":"9","author":"Star","year":"2000","journal-title":"J Matern Fetal Med"},{"issue":"7","key":"zoi251405r7","doi-asserted-by":"publisher","first-page":"683","DOI":"10.3109\/14767058.2013.832750","article-title":"The association of antenatal corticosteroids with neonatal hypoglycemia and hyperbilirubinemia.","volume":"27","author":"Pettit","year":"2014","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"6","key":"zoi251405r8","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1016\/j.jpeds.2015.02.045","article-title":"Re-evaluating \u201ctransitional neonatal hypoglycemia\u201d: mechanism and implications for management.","volume":"166","author":"Stanley","year":"2015","journal-title":"J Pediatr"},{"issue":"1","key":"zoi251405r9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1542\/peds.2007-2822","article-title":"Patterns of cerebral injury and neurodevelopmental outcomes after symptomatic neonatal hypoglycemia.","volume":"122","author":"Burns","year":"2008","journal-title":"Pediatrics"},{"issue":"2","key":"zoi251405r10","doi-asserted-by":"publisher","first-page":"e265","DOI":"10.1542\/peds.2012-0079","article-title":"Neonatal morbidities and developmental delay in moderately preterm-born children.","volume":"130","author":"Kerstjens","year":"2012","journal-title":"Pediatrics"},{"issue":"2","key":"zoi251405r11","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1159\/000492859","article-title":"Neonatal glycaemia and neurodevelopmental outcomes: a systematic review and meta-analysis.","volume":"115","author":"Shah","year":"2019","journal-title":"Neonatology"},{"issue":"3","key":"zoi251405r12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.siny.2019.03.001","article-title":"Antenatal corticosteroids after 34 weeks\u2019 gestation: do we have the evidence?","volume":"24","author":"Groom","year":"2019","journal-title":"Semin Fetal Neonatal Med"},{"key":"zoi251405r13","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9804708","article-title":"Comparative efficacy and safety of metformin, glyburide, and insulin in treating gestational diabetes mellitus: a meta-analysis.","volume":"2019","author":"Guo","year":"2019","journal-title":"J Diabetes Res"},{"issue":"3","key":"zoi251405r14","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2337\/dc16-2307","article-title":"Glyburide versus metformin and their combination for the treatment of gestational diabetes mellitus: a randomized controlled study.","volume":"40","author":"Nachum","year":"2017","journal-title":"Diabetes Care"},{"issue":"2","key":"zoi251405r15","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1097\/AOG.0000000000002501","article-title":"ACOG Practice Bulletin No. 190: gestational diabetes mellitus.","volume":"131","author":"ACOG Practice Bulletin No","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"2","key":"zoi251405r16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2165\/11534750-000000000-00000","article-title":"Clinical pharmacokinetics of metformin.","volume":"50","author":"Graham","year":"2011","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"zoi251405r17","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/AOG.0000000000005447","article-title":"First and second stage labor management: ACOG Clinical Practice Guideline No. 8.","volume":"143","author":"First and Second Stage Labor Management","year":"2024","journal-title":"Obstet Gynecol"},{"issue":"2","key":"zoi251405r18","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ajog.2004.01.055","article-title":"The postprandial glucose profile in the diabetic pregnancy.","volume":"191","author":"Ben-Haroush","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"zoi251405r19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1515\/JPM.2005.024","article-title":"Optimal timing for postprandial glucose measurement in pregnant women with diabetes and a non-diabetic pregnant population evaluated by the Continuous Glucose Monitoring System (CGMS).","volume":"33","author":"B\u00fchling","year":"2005","journal-title":"J Perinat Med"},{"key":"zoi251405r20","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.634305","article-title":"Neonatal hypoglycemia and brain vulnerability.","volume":"12","author":"De Angelis","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"zoi251405r21","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.3082","article-title":"Prevalence of multiplicity and appropriate adjustments among cardiovascular randomized clinical trials published in major medical journals.","volume":"3","author":"Khan","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"4","key":"zoi251405r22","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0261-3794(99)00028-1","article-title":"Loess: a nonparametric, graphical tool for depicting relationships between variables.","volume":"19","author":"Jacoby","year":"2000","journal-title":"Elect Stud"},{"issue":"2","key":"zoi251405r23","doi-asserted-by":"publisher","first-page":"138","DOI":"10.5863\/1551-6776-20.2.138","article-title":"Metabolic and hormonal effects of antenatal betamethasone after 35 weeks of gestation.","volume":"20","author":"Sifianou","year":"2015","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"19","key":"zoi251405r24","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1056\/NEJMoa0707943","article-title":"Hyperglycemia and adverse pregnancy outcomes.","volume":"358","author":"Metzger","year":"2008","journal-title":"N Engl J Med"},{"issue":"9","key":"zoi251405r25","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.eprac.2024.05.017","article-title":"Long-term impact on offspring (5 to 11 years of age) of metformin use in pregnancy in mothers with diabetes: a systematic review and meta-analysis.","volume":"30","author":"Dutta","year":"2024","journal-title":"Endocr Pract"},{"issue":"3","key":"zoi251405r26","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ajog.2024.02.316","article-title":"Metformin in pregnancy and childhood neurodevelopmental outcomes: a systematic review and meta-analysis.","volume":"231","author":"Gordon","year":"2024","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"zoi251405r27","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010564.pub2","article-title":"Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.","volume":"7","author":"Dodd","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"22","key":"zoi251405r28","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1001\/jama.2023.22949","article-title":"Metformin plus insulin for preexisting diabetes or gestational diabetes in early pregnancy: the MOMPOD randomized clinical trial.","volume":"330","author":"Boggess","year":"2023","journal-title":"JAMA"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2843520\/yefet_2026_oi_251405_1776353082.0445.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T16:00:17Z","timestamp":1776355217000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2843520"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.52807","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]}}}